Neurologic Stem Cell Treatment Study
Public ClinicalTrials.gov record NCT02795052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neurologic Bone Marrow Derived Stem Cell Treatment Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/
Study identification
- NCT ID
- NCT02795052
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 500 participants
Conditions and interventions
Conditions
- Neurologic Disorders
- Nervous System Diseases
- Neurodegenerative Diseases
- Neurological Disorders
- Stroke
- Traumatic Brain Injury
- Cadasil
- Chronic Traumatic Encephalopathy
- Cerebral Infarction
- Cerebral Ischemia
- Cerebral Stroke
- Cerebral Hemorrhage
- Parkinson
- Multi-System Degeneration
- MSA - Multiple System Atrophy
- Progressive Supranuclear Palsy
- ALS
- Amyotrophic Lateral Sclerosis
- Neuropathy
- Diabetic Neuropathies
- Alzheimer Disease
- Dementia
- Frontotemporal Dementia
- Lewy Body Disease
- Cognitive Impairment
- Lewy Body Variant of Alzheimer Disease
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- Jul 30, 2027
- Completion
- Jul 30, 2028
- Last update posted
- Jun 25, 2026
2016 – 2028
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MD Stem Cells | Westport | Connecticut | 06880 | Recruiting |
| MD Stem Cells | Coral Springs | Florida | 33065 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02795052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02795052 live on ClinicalTrials.gov.